MarketPulse
M

$MASI

7 articles found
4 positive
2 negative
1 neutral
The Motley FoolThe Motley Fool··Justin Pope

Danaher Stock Plunges 36% but Masimo Deal Signals Recovery Ahead

Danaher trades 31% below historical valuation after 36% decline, but Masimo acquisition and resumed growth suggest recovery is underway for the storied life sciences leader.
DHRMASIacquisitionfree cash flow
BenzingaBenzinga··Monteverde & Associates Pc

Class Action Firm Probes Four Major M&A Deals as Shareholder Votes Loom

Monteverde & Associates investigates four merger transactions including Masimo's $180/share Danaher sale, with shareholder votes scheduled for May 1, 2026.
MASIIBCPHCBNVYNEclass actionmerger investigation
The Motley FoolThe Motley Fool··Jonathan Ponciano

Bridger's $7M Masimo Exit Proved Costly as $9.9B Acquisition Sparked 34% Rally

Bridger Management sold its $7M Masimo stake after 12% decline; weeks later, a $9.9B acquisition sparked 34% surge, highlighting investment timing risks.
MSMSpAMSpEMSpFMSpI+8acquisitionportfolio management
BenzingaBenzinga··Prnewswire

Legal Firm Initiates M&A Investigations Into Four Major Transactions

Legal firm Monteverde & Associates launches investigations into four major M&A deals, examining whether shareholder valuations and board fiduciary duties were properly upheld.
KWMASIMCWJFBclass action lawsuitacquisition
GlobeNewswire Inc.GlobeNewswire Inc.··Halper Sadeh Llc

Law Firm Examines Fairness of Three Major Corporate Transactions

Law firm Halper Sadeh investigates three major corporate transactions—VerifyMe-Open World merger, Masimo-Danaher sale, and Valaris-Transocean deal—for potential shareholder fairness violations.
MASIVRMEVALVAL.WSshareholder rightsacquisition
BenzingaBenzinga··Vandana Singh

Danaher to Acquire Masimo for $9.9B in Cash Deal

Danaher acquires Masimo for $9.9 billion in cash, expanding its medical technology portfolio with expected synergies exceeding $175 million annually.
DHRMASIacquisitionM&A
BenzingaBenzinga··Vandana Singh

Danaher to Acquire Masimo for $9.9B in Healthcare Technology Deal

Danaher to acquire Masimo for $9.9 billion, expanding its healthcare technology portfolio. The deal represents a significant premium and major consolidation in medical devices.
AAPLDHRMASIacquisitionstock surge